“If it’s yellow, he’s not going to go near it.” An interesting study showing that patients concerns about a biosimilar’s administration and colour are important to address, and these concerns often stem from negative previous experiences with medicines 💊
754 followers
1,081 followers
RT @AutoimmuneList: Same but different? A thematic analysis on adalimumab biosimilar switching among patients with juvenile idiopathic arth…
622 followers
RT @AutoimmuneList: Same but different? A thematic analysis on adalimumab biosimilar switching among patients with juvenile idiopathic arth…
9,326 followers
Same but different? A thematic analysis on adalimumab biosimilar switching among patients with juvenile idiopathic arthritis https://t.co/0PsAPhQRic